Saudi Arabia’s Capital Market Authority (CMA) on Sunday approved Dallah Healthcare Company's request to increase its capital from SAR 590 million to SAR 750 million, through issuance of one bonus share for every 3.69 existing shares owned by the shareholders.
The capital hike will be financed by transferring SAR 160 million from statutory reserve to the company's capital.
Accordingly, Dallah’s outstanding shares will be increased from 59 million to 75 million shares.
The extraordinary general assembly should be held within six months from this approval date and the company should satisfy all regulatory requirements and applicable laws, the statement added.
Argaam Investment Company has updated the Privacy Policy of its services and digital platforms. Know more about our Privacy Policy here.
Argaam uses cookies to personalize content, to provide social media features and analyze traffic, that we might also share with third parties. You consent to our cookies if you use this website
Comments {{getCommentCount()}}
Be the first to comment
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}